Study patients, n |
573 |
1,719 |
|
Age, mean (± SD), years |
71.7 (± 13.5) |
71.7 (± 13.5) |
1.0 |
Women, n (%) |
272 (47.4) |
822 (47.8) |
0.92 |
Ethnicity, n (%) |
|
|
|
White |
455 (79.4) |
1,381 (80.3) |
0.27 |
Black |
56 (9.8) |
133 (7.7) |
Hispanic |
28 (4.9) |
76 (4.4) |
Other (includes unknown) |
34 (5.9) |
129 (7.5) |
English is the primary language, n (%) |
521 (90.8) |
1,580 (91.9) |
0.51 |
Health insurance, n (%) |
|
|
|
Private |
110 (19.2) |
475 (27.6) |
0.0002 |
Medicare |
414 (72.3) |
1,149 (66.8) |
Medicaid |
42 (7.3) |
83 (4.8) |
Uninsured |
7 (1.2) |
12 (0.7) |
HEMORR2HAGES score, mean (± SD) |
2.1 (1.5) |
2.1 (± 1.5) |
0.88 |
Serum creatinine, mean (± SD), mg/dL |
2.3 (1.9) |
2.0 (± 1.6) |
0.0012 |
Platelet count < 100,000 / μl, n (%) |
127 (22.2) |
360 (20.9) |
0.58 |
Liver disease, n (%) |
17 (3.0) |
31 (1.8) |
0.13 |
Alcohol abuse, n (%) |
9 (1.6) |
51 (3.0) |
0.097 |
Malignancy, n (%) |
178 (31.1) |
587 (34.1) |
0.19 |
Prior hemorrhage, n (%) |
28 (4.9) |
25 (1.5) |
< 0.0001 |
Uncontrolled Hypertension, n (%) |
11 (1.9) |
38 (2.2) |
0.81 |
Anemia, n (%) |
215 (37.5) |
486 (28.3) |
< 0.0001 |
Dementia / Parkinson’s disease, n (%) |
50 (8.7) |
254 (14.8) |
0.0003 |
Prior stroke, n (%) |
155 (27.1) |
479 (27.9) |
0.75 |
Complex warfarin regimen, n (%) |
65 (11.3) |
193 (11.2) |
1.0 |